Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new highs.Biotechnology […]
CORAL GABLES, FL / ACCESSWIRE / February 11, 2015 / It’s been a long and rough road for a push toward universal legalization of marijuana in the US. Since the early beginnings in California many decades ago with medical marijuana to the latest trail being blazed from states like Colorado, Oregon, Washington, and Alaska, this has certainly become a growth […]
LONDON, January 28, 2015 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Halozyme Therapeutics Inc. (NASDAQ: HALO), Agenus Inc. (NASDAQ: AGEN), Biogen Idec Inc. (NASDAQ: BIIB), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), and Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). Free research report on Halozyme Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Halozyme%20Therapeutics&d=28-Jan-2015&s=HALO. On Tuesday, January 27, 2015, the NASDAQ Composite ended at 4,681.50, […]
Under agreement with StreetWise Reports, I’m pleased to share their recent coverage of the regenerative medicine sector.Original Source: Source: Peter Byrne of The Life Sciences Report (1/22/15)”Convert Catalysts into Profits: Sagient Research’s Edward Stopke“The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. But realistically assessing the therapeutic potential of pipeline […]
Leading Health Care Stock for Small-Cap Stars is Athersys Inc. (ATHX) for January 20
By iCELL News on January 22, 2015 · Investing
Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com’s Small-Cap Stars, our proprietary list of small-cap companies with characteristics we’ve found […]
View photo.Deutsche Bank on Thursday named its top Small-Cap Biotech picks for 2015. The top picks were selected because they were either a disruptive technology, a rare or orphan disease market, an unmet need market or a stock with a big-time catalyst.Here is what to watch for in Deutsche’s top picks.
PTC Therapeutics, Inc. (NASDAQ: PTCT)
Deutsche highlighted PTC Therapeutics as its […]
What Investors Are Looking At In The Stem Cell Sector
By iCELL News on January 14, 2015 · Sector
Stem cell stocks did poorly in 2014.However, many of these companies have catalysts in the first quarter of 2015 that could bring attention to the sector.In anticipation of a Phase 2 clinical update, Brainstorm Cell Therapeutics IncBCLI 1.89%stock rallied nearly 100 percent. The […]
View gallery.Stocks have been getting hit pretty hard over the last week. The new year has started off somewhat like 2014 did — down.Some individual industries are holding up a little better than others, such as gold miners, REITs and airlines.Biotech stocks have held on relatively well, too.Biotech names such as Agios Pharmaceuticals (NASDAQ: AGIO) and Incyte Corp (NASDAQ: INCY) […]
Many biotech stocks have been breaking out over the past two months.Newlink Genetics Corp and Incyte Corporation both skyrocketed in October.After that, stocks of Ariad Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. both had nice, quick pops last month.Then there was Kite Pharma Inc’s huge jump earlier this month.So, Who’s Next?The Company: Sangamo Biosciences, Inc.Ticker Symbol: (NASDAQ: SGMO)Sector: HealthcareIndustry: BiotechnologySangamo focuses […]
ORLANDO, Fla., Dec. 5, 2014 (GLOBE NEWSWIRE) — A shelf registration (commonly known as an S-3 filing) is a public offering which allows companies to offer and sell securities without having to file separate prospectuses for each raise. Typically, the maximum amount that can raised through one of these documents is $100 million. Looking at biotech and medtech stocks that […]
